Skip to main navigation
Leap therapeutics
Leap therapeutics
  • About
    • About
    • Contact Us
  • Indications
    • Indications
    • Gastric Cancer
    • Endometrial Cancer
    • Prostate Cancer
    • Lung Cancer
    • Partnership
  • Science
    • Science
    • DKK1
    • DKN-01
  • Patients
  • Careers
  • Investors
    • Investors
    • Stock Information
    • News Releases
    • Presentations & Events
    • Financial Information
    • Corporate Governance
    • Information Request

News
Releases

image description

News Releases

May 26, 2022
Leap Therapeutics to Present Initial Data from the Investigator-Sponsored Study of DKN-01 Plus Docetaxel in Patients with Prostate Cancer at the 2022 ASCO Annual Meeting
May 13, 2022
Leap Therapeutics Reports First Quarter 2022 Financial Results
Mar 11, 2022
Leap Therapeutics Reports Fourth Quarter and Full Year 2021 Financial Results
Mar 02, 2022
Leap Therapeutics to Present at Raymond James 43rd Annual Institutional Investors Conference
Jan 31, 2022
Leica Biosystems and Leap Therapeutics Partner on Companion Diagnostic to Advance Care for Cancer Patients
Jan 24, 2022
Leap Therapeutics to Present at B. Riley Securities Oncology Investor Conference
Jan 18, 2022
Leap Therapeutics to Present Positive New Data from the DisTinGuish Study of DKN-01 Plus Tislelizumab at the ASCO GI Cancers Symposium
Jan 05, 2022
Leap Therapeutics to Present at H.C. Wainwright BioConnect 2022 Conference
Jan 03, 2022
Leap Therapeutics to Present at 40th Annual J.P. Morgan Healthcare Conference
  • image Print Page Print Page
  • image Email Alerts Email Alerts
  • image Contact Us Contact Us
image description
image description
Leap therapeutics
47 Thorndike Street, Suite B1-1 Cambridge, MA 02141 USA
+1 617 714 0360

Business inquiries
bd@leaptx.com

Investor inquiries
ir@leaptx.com

About

Contact Us

Careers

Indications

  • Gastric Cancer
  • Endometrial Cancer
  • Prostate Cancer
  • Lung Cancer
  • Partnership

Science

  • DKK1
  • DKN-01

Patients

Investors

  • Stock Information
  • News Releases
  • Presentations & Events
  • Financial Information
  • Corporate Governance
  • Information Request
  • © 2022 Leap Therapeutics, Inc.
  • All Rights Reserved.
  • Terms of Use
  • Privacy Policy